5-(2-chloroethylamino)-2-methyl-2H-pyridazine-3-one hydrochloride | 504397-29-9

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二嗪类
• 英文名称: 5-(2-chloroethylamino)-2-methyl-2H-pyridazine-3-one hydrochloride
• 英文别名: 5-(2-Chloroethylamino)-2-methyl-2h-pyridazine-3-one-hydrochloride；5-(2-chloroethylamino)-2-methylpyridazin-3-one;hydrochloride
• CAS: 504397-29-9
• 化学式: C₇H₁₀ClN₃O*ClH
• 分子量: 224.09
• InChiKey: UNCCAIQGUYSQRY-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.85
• 重原子数：
  13
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.43
• 拓扑面积：
  44.7
• 氢给体数：
  2
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  5-(2-chloroethylamino)-2-methyl-2H-pyridazine-3-one hydrochloride 、 6-氟-3-(哌啶-4-基)苯并[D]异恶唑 在 potassium carbonate 、 potassium iodide 作用下， 以 乙腈 为溶剂， 反应 24.0h， 以55.9%的产率得到5-{2-[4-(6-fluoro-1,2-benzisoxazole-3-yl)-piperidine-1-yl]-ethylamino}-2-methyl-2H-pyridazine-3-one
  参考文献：
  名称：

  [EN] NEW PIPERIDINYL-ALKYLAMINO-PYRIDAZINONE DERIVATIVES, A PROCESS FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAID COMPOUNDS
  [FR] NOUVEAUX DERIVES DE PIPERIDINYL-ALKYLAMINO-PYRIDAZINONE, PROCEDE DE PREPARATION DE CEUX-CI ET COMPOSITIONS PHARMACEUTIQUES CONTENANT CES COMPOSES

  摘要：

  本发明涉及一种新的吡哆啉基-烷基氨基-吡啶嗪酮衍生物，其一般式为（I）（其中R为氢或C1-4-烷基；X和Y中的一个代表氢，另一个代表一般式（II）的基团，Hal代表卤素；n为1或2），以及其药学上可接受的酸加成盐的制备方法和包含所述化合物的制剂。一般式I的化合物具有抗焦虑作用，可用于治疗焦虑症。

  公开号：

  WO2003091244A1

文献信息

• Heterocyclic compounds, which are inhibitors of the enzyme DPP-IV
  申请人：——

  公开号：US20020161001A1

  公开（公告）日：2002-10-31

  The present invention relates to therapeutically active and selective inhibitors of the enzyme DPP-IV, pharmaceutical compositions comprising the compounds and the use of such compounds for and the manufacture of medicaments for treating diseases that are associated with proteins which are subject to inactivation by DPP-IV, such as type 2 diabetes and obesity, as well as methods for treating diseases that are associated with proteins which are subject to inactivation by DPP-IV, such as type 2 diabetes and obesity

  本发明涉及治疗活性和选择性抑制剂酶DPP-IV，包含该化合物的药物组合物以及利用这些化合物制造用于治疗与DPP-IV使蛋白质失活有关的疾病的药物，例如2型糖尿病和肥胖症，以及治疗与DPP-IV使蛋白质失活有关的疾病的方法，例如2型糖尿病和肥胖症。
• [EN] SUBSTITUTED ALKYLAMINOPYRIDAZINONE DERIVATIVES, PROCESS FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME<br/>[FR] DERIVES SUBSTITUES D'ALKYLAMINOPYRIDAZINONE, PROCEDES DE PREPARATION ET COMPOSITION PHARMACEUTIQUE LES CONTENANT
  申请人：EGYT GYOGYSZERVEGYESZETI GYAR

  公开号：WO2003027097A1

  公开（公告）日：2003-04-03

  The invention relates to new substituted alkylaminopyridazinone derivatives of the general Formula (I), (wherein R1 is hydrogen or alkyl having 1-4 carbon atoms; one of X and Y stands for hydrogen or halogen and the other represents a group of the general Formula (II), R2 is hydrogen or alkyl having 1-4 carbon atoms; n is 1, 2 or 3; R3 stands for hydrogen, alkyl having 1-4 carbon atoms or aryl-(C1-4 alkyl); Z stands for oxygen; or R3 and Z together with the groups placed between them form a piperazine ring; and R4 stands for hydrogen, halogen, trifluoromethyl or alkoxy having 1-4 carbon atoms) and pharmaceutically acceptable acid addition salts thereof. The invention compounds are useful in the treatment of anxiolytic conditions and cognitive disorders.

  本发明涉及一种新的取代烷基氨基吡嗪酮衍生物，其通式为（I），其中R1为氢或具有1-4个碳原子的烷基；X和Y中的一个代表氢或卤素，另一个代表通式（II）的基团，R2为氢或具有1-4个碳原子的烷基；n为1、2或3；R3代表氢、具有1-4个碳原子的烷基或芳基-(C1-4烷基)；Z代表氧；或R3和Z与它们之间放置的基团一起形成哌嗪环；R4代表氢、卤素、三氟甲基或具有1-4个碳原子的烷氧基；以及其药学上可接受的酸加盐。本发明化合物在治疗抗焦虑症和认知障碍方面有用。
• Piperidinyl-alkylamino-pyridazinone derivatives, a process for the preparation thereof and pharmaceutical compositions containing said compounds
  申请人：Barkoczy Jozsef

  公开号：US20050215560A1

  公开（公告）日：2005-09-29

  The invention relates to new piperidinyl-alkylamino-pyridazinone derivatives of the general Formula (I) (wherein R is hydrogen or C 1-4 -alkyl; one of X and Y stands for hydrogen and the other represents a group of the general Formula (II) Hal stands for halogen; and n is 1 or 2) and pharmaceutically acceptable acid addition salts thereof a process for the preparation thereof and pharmaceutical compositions comprising said compounds. The compounds of the general Formula I exhibit anxiolytic effect and are useful in the treatment of anxiety.

  本发明涉及新的哌啶基-烷基氨基-吡啶嗪酮衍生物，其一般式为(I)，其中R为氢或C1-4-烷基；X和Y中的一个表示氢，另一个表示一般式(II)的基团，Hal表示卤素；n为1或2。还涉及其药学上可接受的酸盐制备方法和含有该化合物的药物组合物。一般式I的化合物表现出抗焦虑作用，可用于焦虑症的治疗。
• Heterocyclic compounds that are inhibitors of the enzyme DPP-IV
  申请人：NOVO NORDISK A/S

  公开号：EP1561752A1

  公开（公告）日：2005-08-10

  The present invention relates to therapeutically active and selective inhibitors of the enzyme DPP-IV, pharmaceutical compositions comprising the compounds and the use of such compounds for and the manufacture of medicaments for treating diseases that are associated with proteins which are subject to inactivation by DPP-IV, such as type 2 diabetes and obesity, as well as methods for treating diseases that are associated with proteins which are subject to inactivation by DPP-IV, such as type 2 diabetes and obesity.

  本发明涉及具有治疗活性和选择性的DPP-IV酶抑制剂、包含这些化合物的药物组合物、使用这些化合物治疗与DPP-IV灭活的蛋白质有关的疾病（如2型糖尿病和肥胖症）的药物以及治疗与DPP-IV灭活的蛋白质有关的疾病（如2型糖尿病和肥胖症）的方法。
• Substituted alkylaminopyridazinone derivatives, process for the preparation thereof and pharmaceutical composition containing the same
  申请人：——

  公开号：US20040242873A1

  公开（公告）日：2004-12-02

  The invention relates to new substituted alkylaminopyridazinone derivatives of the general Formula (I), (wherein R 1 is hydrogen or alkyl having 1-4 carbon atoms; one of X and Y stands for hydrogen or halogen and the other represents a group of the general Formula (II), R 2 is hydrogen or alkyl having 1-4 carbon atoms; n is 1, 2 or 3; R 3 stands for hydrogen, alkyl having 1-4 carbon atoms or aryl-(C 1-4 alkyl); Z stands for oxygen; or R 3 and Z together with the groups placed between them form a piperazine ring; and R 4 stands for hydrogen, halogen, trifluoromethyl or alkoxy having 1-4 carbon atoms) and pharmaceutically acceptable acid addition salts thereof. The invention compounds are useful in the treatment of anxiolytic conditions and cognitive disorders. 1

  本发明涉及通式（I）的新取代烷基氨基哒嗪酮衍生物（其中 R 1 是氢或具有 1-4 个碳原子的烷基；X 和 Y 中的一个代表氢或卤素，另一个代表通式（II）的基团，R 2 是氢或具有 1-4 个碳原子的烷基；n 是 1、2 或 3；R 3 代表氢、具有 1-4 个碳原子的烷基或芳基-(C 1-4 烷基）；Z 代表氧；或 R 3 和 Z 与它们之间的基团一起构成一个哌嗪环；以及 R 4 代表氢、卤素、三氟甲基或具有 1-4 个碳原子的烷氧基）及其药学上可接受的酸加成盐。本发明化合物可用于治疗抗焦虑症状和认知障碍。 1